139 related articles for article (PubMed ID: 1692492)
1. Specific recognition of human leukemic cells by allogeneic T cells: II. Evidence for HLA-D restricted determinants on leukemic cells that are crossreactive with determinants present on unrelated nonleukemic cells.
Sosman JA; Oettel KR; Smith SD; Hank JA; Fisch P; Sondel PM
Blood; 1990 May; 75(10):2005-16. PubMed ID: 1692492
[TBL] [Abstract][Full Text] [Related]
2. Specific recognition of human leukemic cells by allogeneic T cell lines.
Sosman JA; Oettel KR; Hank JA; Fisch P; Sondel PM
Transplantation; 1989 Sep; 48(3):486-95. PubMed ID: 2571206
[TBL] [Abstract][Full Text] [Related]
3. Frequency of bone marrow T cells responding to HLA-identical non-leukemic and leukemic stimulator cells.
Hoffmann T; Theobald M; Bunjes D; Weiss M; Heimpel H; Heit W
Bone Marrow Transplant; 1993 Jul; 12(1):1-8. PubMed ID: 8374531
[TBL] [Abstract][Full Text] [Related]
4. Recognition of leukemic blasts by HLA-DPB1-specific cytotoxic T cell clones: a perspective for adjuvant immunotherapy post-bone marrow transplantation.
Ibisch C; Gallot G; Vivien R; Diez E; Jotereau F; Garand R; Vié H
Bone Marrow Transplant; 1999 Jun; 23(11):1153-9. PubMed ID: 10382955
[TBL] [Abstract][Full Text] [Related]
5. CD80-Transfected acute myeloid leukemia cells induce primary allogeneic T-cell responses directed at patient specific minor histocompatibility antigens and leukemia-associated antigens.
Mutis T; Schrama E; Melief CJ; Goulmy E
Blood; 1998 Sep; 92(5):1677-84. PubMed ID: 9716596
[TBL] [Abstract][Full Text] [Related]
6. Recognition of clonogenic leukemic cells, remission bone marrow and HLA-identical donor bone marrow by CD8+ or CD4+ minor histocompatibility antigen-specific cytotoxic T lymphocytes.
Faber LM; van der Hoeven J; Goulmy E; Hooftman-den Otter AL; van Luxemburg-Heijs SA; Willemze R; Falkenburg JH
J Clin Invest; 1995 Aug; 96(2):877-83. PubMed ID: 7635982
[TBL] [Abstract][Full Text] [Related]
7. Generation of CD4+ cytotoxic T-lymphocyte clones from a patient with severe graft-versus-host disease after allogeneic bone marrow transplantation: implications for graft-versus-leukemia reactivity.
Faber LM; van Luxemburg-Heijs SA; Veenhof WF; Willemze R; Falkenburg JH
Blood; 1995 Oct; 86(7):2821-8. PubMed ID: 7670118
[TBL] [Abstract][Full Text] [Related]
8. Correlation of minor histocompatibility antigen-specific cytotoxic T lymphocytes with graft-versus-host disease status and analyses of tissue distribution of their target antigens.
Niederwieser D; Grassegger A; Auböck J; Herold M; Nachbaur D; Rosenmayr A; Gächter A; Nussbaumer W; Gaggl S; Ritter M
Blood; 1993 Apr; 81(8):2200-8. PubMed ID: 8471780
[TBL] [Abstract][Full Text] [Related]
9. HLA identical leukemia cells and T cell growth factor activate cytotoxic T cell recognition of minor locus histocompatibility antigens in vitro.
Sondel PM; Hank JA; Wendel T; Flynn B; Bozdech MJ
J Clin Invest; 1983 Jun; 71(6):1779-86. PubMed ID: 6223050
[TBL] [Abstract][Full Text] [Related]
10. Allogeneic T-cell clones able to selectively destroy Philadelphia chromosome-bearing (Ph1+) human leukemia lines can also recognize Ph1- cells from the same patient.
Oettel KR; Wesly OH; Albertini MR; Hank JA; Iliopolis O; Sosman JA; Voelkerding K; Wu SQ; Clark SS; Sondel PM
Blood; 1994 Jun; 83(11):3390-402. PubMed ID: 8193377
[TBL] [Abstract][Full Text] [Related]
11. Direct recognition and lysis of leukemia cells by WT1-specific CD4+ T lymphocytes in an HLA class II-restricted manner.
Guo Y; Niiya H; Azuma T; Uchida N; Yakushijin Y; Sakai I; Hato T; Takahashi M; Senju S; Nishimura Y; Yasukawa M
Blood; 2005 Aug; 106(4):1415-8. PubMed ID: 15845894
[TBL] [Abstract][Full Text] [Related]
12. Acute graft-versus-host disease after bone marrow transplantation with a single HLA-DPB1*1001 mismatch: involvement of different TCRBV subsets.
Gaschet J; Gallot G; Ibisch C; Lim A; Even J; Vivien R; Hallet MM; Milpied N; Vié H
Bone Marrow Transplant; 1998 Aug; 22(4):385-92. PubMed ID: 9722075
[TBL] [Abstract][Full Text] [Related]
13. Downregulation of HLA class II is associated with relapse after allogeneic stem cell transplantation and alters recognition by antigen-specific T cells.
Adachi Y; Sakai T; Terakura S; Shiina T; Suzuki S; Hamana H; Kishi H; Sasazuki T; Arase H; Hanajiri R; Goto T; Nishida T; Murata M; Kiyoi H
Int J Hematol; 2022 Mar; 115(3):371-381. PubMed ID: 35037229
[TBL] [Abstract][Full Text] [Related]
14. The allogeneic HLA-DP-restricted T-cell repertoire provoked by allogeneic dendritic cells contains T cells that show restricted recognition of hematopoietic cells including primary malignant cells.
Laghmouchi A; Hoogstraten C; van Balen P; Falkenburg JHF; Jedema I
Haematologica; 2019 Jan; 104(1):197-206. PubMed ID: 30237261
[TBL] [Abstract][Full Text] [Related]
15. Generation of donor-derived antileukemic cytotoxic T-lymphocyte responses for treatment of relapsed leukemia after allogeneic HLA-identical bone marrow transplantation.
Falkenburg JH; Faber LM; van den Elshout M; van Luxemburg-Heijs SA; Hooftman-den Otter A; Smit WM; Voogt PJ; Willemze R
J Immunother Emphasis Tumor Immunol; 1993 Nov; 14(4):305-9. PubMed ID: 8280712
[TBL] [Abstract][Full Text] [Related]
16. Antigen-specific recognition of autologous leukemia cells and allogeneic class-I MHC antigens by IL-2-activated cytotoxic T cells from a patient with acute T-cell leukemia.
Fisch P; Weil-Hillman G; Uppenkamp M; Hank JA; Chen BP; Sosman JA; Bridges A; Colamonici OR; Sondel PM
Blood; 1989 Jul; 74(1):343-53. PubMed ID: 2546621
[TBL] [Abstract][Full Text] [Related]
17. Growth inhibition of clonogenic leukemic precursor cells by minor histocompatibility antigen-specific cytotoxic T lymphocytes.
Falkenburg JH; Goselink HM; van der Harst D; van Luxemburg-Heijs SA; Kooy-Winkelaar YM; Faber LM; de Kroon J; Brand A; Fibbe WE; Willemze R
J Exp Med; 1991 Jul; 174(1):27-33. PubMed ID: 2056279
[TBL] [Abstract][Full Text] [Related]
18. Human T cell receptor-gamma delta-expressing T-cell lines recognize MHC-controlled elements on autologous EBV-LCL that are not HLA-A, -B, -C, -DR, -DQ, or -DP.
Lam V; DeMars R; Chen BP; Hank JA; Kovats S; Fisch P; Sondel PM
J Immunol; 1990 Jul; 145(1):36-45. PubMed ID: 1694208
[TBL] [Abstract][Full Text] [Related]
19. Cytotoxic T-lymphocyte-defined human minor histocompatibility antigens with a restricted tissue distribution.
Warren EH; Greenberg PD; Riddell SR
Blood; 1998 Mar; 91(6):2197-207. PubMed ID: 9490709
[TBL] [Abstract][Full Text] [Related]
20. Multiple minor histocompatibility antigen disparities between a recipient and four HLA-identical potential sibling donors for bone marrow transplantation.
Marijt EA; Veenhof WF; Goulmy E; Kluck PM; Brand A; Willemze R; van Rood JJ; Falkenburg JH
Hum Immunol; 1993 Aug; 37(4):221-8. PubMed ID: 8300407
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
